← Leaderboards
Suzanne Elizabeth Lapi
University Of Alabama At Birmingham
$6,151,104
Attributed
$6,454,519
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,454,519 · 8
By mechanism
P01$3,468,259 · 2
R01$1,334,963 · 1
R41$574,808 · 2
P30$457,959 · 1
R21$381,830 · 1
S10$236,700 · 1
Top collaborators
- Renata Jaskula-Sztul1 shared
- David Allen Ralph1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Delia Smith West$10,703,923
- Renee A. Heffron$19,065,543
- Edward E Partridge$43,798,134
- Eric Hunter$78,178,241
- George Howard$21,516,429
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageImaging AgentLabelSpecificityPre-ClinicalTherapeutic AgentsAntibodiesClinical TrialsBaseRadioimmunoconjugatePositron-Emission TomographyRadiolabeledMolecular ImagingCgmp ProductionClinical ResearchMalignant NeoplasmsPumpRadionuclide ImagingRadiopharmaceuticalsPre-Clinical ModelClinical ImagingBiodistributionCaveolaeSolid Neoplasm
Grant awards (19)
02 - Experimental Therapeutics$457,959
P30 · FY2025 · CA · contact PI
A novel platform for targeted radiopharmaceuticals for imaging and therapy of ovarian cancer$349,808
R41 · FY2024 · CA · contact PI
Clinical Trials for Imaging and Therapy$1,034,972
P01 · FY2023 · CA · contact PI
Radiochemistry Core$63,751
P01 · FY2023 · CA · contact PI
Clinical Trials for Imaging and Therapy$864,904
P01 · FY2022 · CA · contact PI
Synthra MeIPlus Research with HCN/CO Options and Radchrom Plus for the UAB Cyclotron Facility$236,700
S10 · FY2022 · OD · contact PI
Radiochemistry Core$175,808
P01 · FY2022 · CA · contact PI
Clinical Trials for Imaging and Therapy$444,757
P01 · FY2021 · CA · contact PI
Radiochemistry Core$127,823
P01 · FY2021 · CA · contact PI
Imaging of alterations in SSTR2 expression with histone deacetylase (HDAC) inhibitors treatment for neuroendocrine tumors$381,830
R21 · FY2020 · CA
Clinical Trials for Imaging and Therapy$296,287
P01 · FY2020 · CA · contact PI
Radiochemistry Core$159,701
P01 · FY2020 · CA · contact PI
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER$326,174
R01 · FY2019 · CA · contact PI
Gallium 68 Tilmanocept for PET Imaging of Atherosclerosis Plaques$225,000
R41 · FY2019 · HL · contact PI
Clinical Trials for Imaging and Therapy$157,931
P01 · FY2019 · CA · contact PI
Radiochemistry Core$142,325
P01 · FY2019 · CA · contact PI
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER$336,263
R01 · FY2018 · CA · contact PI
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER$336,263
R01 · FY2017 · CA · contact PI
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER$336,263
R01 · FY2016 · CA · contact PI